| Literature DB >> 32075770 |
Charleen Salesse1, Julien Charest1, Hélène Doucet-Beaupré1, Anne-Marie Castonguay1, Simon Labrecque1, Paul De Koninck2, Martin Lévesque3.
Abstract
The neurodevelopmental origin of hyperactivity disorder has been suggested to involve the dopaminergic system, but the underlying mechanisms are still unknown. Here, transcription factors Lmx1a and Lmx1b are shown to be essential for midbrain dopaminergic (mDA) neuron excitatory synaptic inputs and dendritic development. Strikingly, conditional knockout (cKO) of Lmx1a/b in postmitotic mDA neurons results in marked hyperactivity. In seeking Lmx1a/b target genes, we identify positively regulated Slitrk2 and negatively regulated Slitrk5. These two synaptic adhesion proteins promote excitatory and inhibitory synapses on mDA neurons, respectively. Knocking down Slitrk2 reproduces some of the Lmx1a/b cKO cellular and behavioral phenotypes, whereas Slitrk5 knockdown has opposite effects. The hyperactivity caused by this imbalance in excitatory/inhibitory synaptic inputs on dopamine neurons is reproduced by chronically inhibiting the ventral tegmental area during development using pharmacogenetics. Our study shows that alterations in developing dopaminergic circuits strongly impact locomotor activity, shedding light on mechanisms causing hyperactivity behaviors.Entities:
Keywords: DREADD; Sholl analysis; VTA; critical period; dendrite; development; locomotion; mice; pharmacogenetic; primary culture
Mesh:
Substances:
Year: 2020 PMID: 32075770 DOI: 10.1016/j.celrep.2020.01.084
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423